EDIT — EDITAS MEDICINE INC

Ownership history in BAILARD, INC.  ·  8 quarters on record

This page tracks every 13F SEC filing in which BAILARD, INC. reported a position in EDITAS MEDICINE INC (EDIT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.02% (2021 Q2)
Avg. % of fund
0.01%
First filed
2021 Q2
Last filed
2025 Q3
Quarters held
8
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 UNCHANGED 33,875 — 0% 0.00% $118K $3.47
2025 Q2 UNCHANGED 33,875 — 0% 0.00% $75K $2.20
2025 Q1 UNCHANGED 33,875 — 0% 0.00% $39K $1.16
2024 Q4 UNCHANGED 33,875 — 0% 0.00% $43K $1.27
4 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    EDIT price (monthly, adj. close)

Other funds also holding EDIT

As of 2025 Q4 — sorted by position size

Green Alpha Advisors, LLC 3Y 0.3% GSA CAPITAL PARTNERS LLP 3Y 7Y 0.1% EntryPoint Capital, LLC 0.07% Eversept Partners, LP 3Y 7Y 0.03% KENNEDY CAPITAL MANAGEMENT LLC 3Y 7Y 0.02% Hennion & Walsh Asset Management, Inc. 3Y 0.02% XTX Topco Ltd 3Y 0.01% DLK Investment Management, LLC 0.01% TWO SIGMA SECURITIES, LLC 3Y 7Y 0.01% Thrive Wealth Management, LLC 3Y 0.01%
← Back to BAILARD, INC. Holdings